Nirma

Nirma is a prominent Indian conglomerate that has strategically diversified into the healthcare and life sciences sectors. Through its healthcare division, Nirlife, and the acquisition of companies like Stericon Pharma and a majority stake in Glenmark Life Sciences, Nirma has become a significant player in the pharmaceutical and medical device markets. The company's product portfolio includes a wide range of intravenous (IV) fluids, medical devices for infusion and blood collection, and active pharmaceutical ingredients (APIs). Nirma operates state-of-the-art manufacturing facilities utilizing Blow-Fill-Seal (BFS) technology and maintains a strong presence in critical care, ophthalmology, and renal care.